| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1046182548 |
| P356 | DOI | 10.1186/1471-2164-11-419 |
| P932 | PMC publication ID | 2996947 |
| P698 | PubMed publication ID | 20604938 |
| P5875 | ResearchGate publication ID | 45095932 |
| P50 | author | Keith O Elliston | Q60665773 |
| Dexter Pratt | Q100953649 | ||
| P2093 | author name string | Rakesh Kumar | |
| Emanuel F Petricoin | |||
| Catherine E Ellis | |||
| Michael Macoritto | |||
| Stephen J Blakemore | |||
| Joseph J Loureiro | |||
| Andrea L Matthews | |||
| P2860 | cites work | Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor | Q22009126 |
| G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells | Q23918913 | ||
| Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue | Q24679625 | ||
| A transforming mutation in the pleckstrin homology domain of AKT1 in cancer | Q27646556 | ||
| TOR, a central controller of cell growth | Q27933354 | ||
| Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer | Q28203143 | ||
| Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors. | Q51966435 | ||
| Mutation analysis of PTEN/MMAC 1 in sporadic thyroid tumors | Q73602035 | ||
| Role of translocation in the activation and function of protein kinase B | Q28609902 | ||
| Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression | Q28679187 | ||
| Ras, PI(3)K and mTOR signalling controls tumour cell growth | Q29614734 | ||
| Exploiting the PI3K/AKT pathway for cancer drug discovery | Q29615120 | ||
| Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 | Q29617097 | ||
| PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model | Q32069431 | ||
| A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3beta/FBW7 loss of function | Q33224746 | ||
| 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport | Q33292269 | ||
| Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo | Q33417863 | ||
| GSK690693 delays tumor onset and progression in genetically defined mouse models expressing activated Akt. | Q33596707 | ||
| A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus | Q33944754 | ||
| Rb-mediated chromatin structure regulation and transcriptional repression | Q34290312 | ||
| Iron chelators as therapeutic agents for the treatment of cancer. | Q34671614 | ||
| Novel targets of Akt, p21(Cipl/WAF1), and MDM2. | Q34759285 | ||
| Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression | Q35948212 | ||
| Regulation of the cytoskeleton: an oncogenic function for CDK inhibitors? | Q35968417 | ||
| Activation of AKT kinases in cancer: implications for therapeutic targeting | Q36226730 | ||
| The Akt/PKB pathway: molecular target for cancer drug discovery | Q36313193 | ||
| The Mad side of the Max network: antagonizing the function of Myc and more. | Q36451356 | ||
| The Myc oncoprotein as a therapeutic target for human cancer | Q36578165 | ||
| Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis | Q36651856 | ||
| Regulation of transferrin receptor expression on human leukemic cells during proliferation and induction of differentiation. Effects of gallium and dimethylsulfoxide | Q36991500 | ||
| The role of hypoxia in 2-butoxyethanol-induced hemangiosarcoma. | Q37478093 | ||
| The transferrin receptor: a key function in iron metabolism | Q38702588 | ||
| Transferrin receptors in human tissues: their distribution and possible clinical relevance | Q39510082 | ||
| Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes | Q39574223 | ||
| Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake | Q39616081 | ||
| AKT inhibitor, GSK690693, induces growth inhibition and apoptosis in acute lymphoblastic leukemia cell lines | Q39907741 | ||
| Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins | Q39959273 | ||
| Overexpression of Akt1 upregulates glycogen synthase activity and phosphorylation of mTOR in IRS-1 knockdown HepG2 cells | Q40089058 | ||
| Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway | Q40256045 | ||
| PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest | Q40702262 | ||
| Activation of transferrin receptor 1 by c-Myc enhances cellular proliferation and tumorigenesis | Q43241094 | ||
| Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activity | Q46670127 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 419 | |
| P577 | publication date | 2010-07-06 | |
| P1433 | published in | BMC Genomics | Q15765854 |
| P1476 | title | Causal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693 | |
| P478 | volume | 11 |
| Q98781281 | A nontoxic fungal natural product modulates fin regeneration in zebrafish larvae upstream of FGF-WNT developmental signaling |
| Q39441173 | AKT signaling pathway activated by HIN-1 methylation in non-small cell lung cancer. |
| Q34288079 | Assessment of network perturbation amplitudes by applying high-throughput data to causal biological networks |
| Q37592031 | Causal analysis approaches in Ingenuity Pathway Analysis |
| Q28730590 | Comparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytes |
| Q33948769 | Construction of a computable cell proliferation network focused on non-diseased lung cells |
| Q40708629 | Construction of biological networks from unstructured information based on a semi-automated curation workflow |
| Q42219330 | Determination of minimal transcriptional signatures of compounds for target prediction |
| Q35143276 | Discovery of 14-3-3 protein-protein interaction inhibitors that sensitize multidrug-resistant cancer cells to doxorubicin and the Akt inhibitor GSK690693. |
| Q50119043 | Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing. |
| Q33596707 | GSK690693 delays tumor onset and progression in genetically defined mouse models expressing activated Akt. |
| Q46936282 | Genes associated with intestinal permeability in ulcerative colitis: changes in expression following infliximab therapy |
| Q28539118 | Leveraging systems biology approaches in clinical pharmacology |
| Q34589738 | Novel pancreatic endocrine maturation pathways identified by genomic profiling and causal reasoning |
| Q30699718 | Reverse causal reasoning: applying qualitative causal knowledge to the interpretation of high-throughput data |
| Q57075201 | Systems Biology Approaches for Compound Testing |
| Q37716386 | Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer |
| Q89292028 | Using microRNA Networks to Understand Cancer |
Search more.